Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: evidence of association but no linkage in a UK sample by Mill, J. et al.
Molecular Psychiatry (2001) 6, 440–444
Ó 2001 Nature Publishing Group All rights reserved 1359-4184/01 $15.00
www.nature.com/mp
ORIGINAL RESEARCH ARTICLE
Attention deficit hyperactivity disorder (ADHD) and the
dopamine D4 receptor gene: evidence of association but
no linkage in a UK sample
J Mill1, S Curran1, L Kent2, S Richards1, A Gould1, V Virdee1, L Huckett1, J Sharp1, C Batten1,
S Fernando1, E Simanoff4, M Thompson3, J Zhao1, P Sham1, E Taylor1 and P Asherson1
1Social, Genetic, and Development Psychiatry Research Centre, Institute of Psychiatry, De Crespigny Park, London SE5
8AF, UK; 2Department of Psychiatry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; 3Child and Family
Health Centre, Ashurst Hospital, Southampton SO40 7AR, UK; 4Department of Child and Adolescent Psychiatry, GKT
Medical School, London SE1 3SS, UK
Keywords: ADHD; DRD4; genetic association
Recent studies report association and linkage between
attention deficit hyperactivity disorder (ADHD) and the
7-repeat allele of a 48 base-pair repeat in the dopamine
D4 receptor gene (DRD4).1 We examined the frequency
of this allele in a sample of probands with DSM-IV ADHD
using a case-control design, as well as the transmission
disequilibrium test (TDT) and haplotype-based haplo-
type relative risk (HHRR) in the subset of probands with
DNA available from both parents. One hundred and
thirty-two ADHD probands were compared with 189 con-
trols (x2 = 6.17, 1 df, P = 0.01, OR = 1.73, 95% CI = 1.11–
2.71). A total of 85 complete trios were available for
within-family tests of association and linkage. Fifty-two
heterozygous parents carrying one copy of the 7-repeat
were informative for the TDT (29 transmitted vs 23 non-
transmitted, x2 = 0.69). Analysis of the entire sample of
132 probands using TRANSMIT2 provided no additional
evidence for excess transmission of the 7-repeat allele
(58 transmitted vs 54 non-transmitted). HHRR gave simi-
lar results. We conclude that the case-control findings
are likely to be falsely positive, resulting from genetic
stratification. However we can not rule out alternative
explanations of low statistical power and gene–environ-
ment correlation. Molecular Psychiatry (2001) 6, 440–444.
Genetic studies aimed at the identification of suscepti-
bility loci for ADHD have focused on genes involved
in the regulation of dopamine neurotransmission. The
most robust finding to date is the association and link-
age between the 7-repeat allele in DRD4 and ADHD.
Nine published studies have shown association or
association and linkage between the 7-repeat and
ADHD,3–11 whereas four have found no association.12–15
A recent meta-analysis of published and unpublished
data suggests a respectable but modest odds ratio (OR)
of 1.9 (95% CI 1.4–2.2, P = 0.00000008) from seven
case-control studies and 1.4 (95% CI 1.1–1.6, P = 0.02)
from 14 family-based studies.16 Here we describe new
data on the association between the 7-repeat allele and
ADHD in two samples from the South of England,
using both case-control and within-family forms of
analysis.
In total, 132 probands with DSM-IV ADHD, were
genotyped and compared with two sets of controls
(Table 1). It was found that the frequency of the 7-
repeat allele among probands was increased compared
to a sample of UK Caucasian children unselected for
phenotype (TEDS sample) (x2 = 5.27, 1 df, P = 0.02) and
a sample of UK Caucasian children selected for low
maternal ratings of hyperactivity (CHIP sample)
(x2 = 3.07, 1 df, P = 0.08). Since frequencies of the major
alleles are similar for the two control samples we can
combine these to compare all cases with all controls
(x2 = 6.17, 1 df, P = 0.01, OR = 1.73, 95% CI = 1.11–
2.71). All the cases in this sample had the combined
subtype (7-repeat frequency = 21.7%), apart from nine
cases with the hyperactive/impulsive subtype (7-repeat
frequency = 11.1%) and three cases with the inattentive
subtype (7-repeat frequency = 33.3%). Within the
ADHD sample, 7-repeat allele frequencies were similar
among nine cases with Axis I comorbidity (22.2%) and
eleven cases with a questionnaire rating suggestive (but
no clinical diagnosis) of pervasive development dis-
order (21.74%). Removal of these cases to define a
refined phenotype under DSM-IV of the combined sub-
type with no Axis I comorbidity gave similar results to
the sample overall (x2 = 6.80, 1 df, P = 0.01).
A total of 85 complete trios were available for
within-family tests of association and linkage (Table 2).
Among these there were 52 heterozygous parents carry-
ing one copy of the 7-repeat allele, informative for the
TDT (29 transmitted vs 23 non-transmitted, x2 = 0.69).
Analysis of the entire sample of 162 probands using
TRANSMIT,2 which estimates probabilities for missing
parental genotypes provided no additional evidence
for excess transmission of the 7-repeat (58 transmitted
vs 54 non-transmitted). We also carried out HHRR by
examining frequencies of transmitted vs non-trans-
mitted parental alleles from the 85 trios. Comparable
with the TDT, we found no evidence for the association
with the 7-repeat (x2 = 0.64) and found that non-trans-
mitted 7-repeat frequencies were more similar to our
cases (18.8% vs 21.1%) than our controls (18.8% vs
13.8%). Furthermore, we observed a 7-repeat fre-
quency of 21% in the parents of the complete trios and
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Table 1 Case-control analysis. Allele counts and frequencies for DRD4 in IOP, UB and control samples
No. of repeats 2 3 4 5 6 7 8 Total
IOP
Total 23 10 121 5 1 44 0 204
(11.27%) (4.90%) (59.31%) (2.45%) (0.49%) (21.57%) (0%)
Combined subtype 21 10 113 4 1 41 0 190
(11.05%) (5.26%) (59.47%) (2.11%) (0.53%) (21.58%) (0%)
Birmingham
Total 5 2 40 1 0 12 0 60
(8.33%) (3.33%) (66.67%) (1.67%) (0%) (20.0%) (0%)
Combined subtype 3 1 34 1 0 11 0 50
(6.0%) (2.0%) (68.0%) (2.0%) (0%) (22.0%) (0%)
IOP + Birmingham
Total 28 12 161 6 1 56 0 264
(10.61%) (4.55%) (60.98%) (2.27%) (0.38%) (21.21%) (0%)
Combined subtype 24 11 147 5 1 52 0 240
(10.0%) (4.58%) (61.25%) (2.08%) (0.42%) (21.67%) (0%)
Controls
CHIP low SDQ 20 6 119 4 0 26 3 178
(11.2%) (3.4%) (66.9%) (2.2%) (0%) (14.6%) (1.7%)
TEDS 18 18 137 0 1 26 0 200
(9.00%) (9.00%) (68.5%) (0%) (0.5%) (13%) (0%)
Combined 38 24 256 4 1 52 3 378
(10.00%) (6.34%) (67.7%) (1.1%) (0.3%) (13.8%) (0.8%)
Table 2 Haplotype-based haplotype relative risk. Trans-
mitted and untransmitted parental alleles for 85 complete
trios
No. of repeats Not 7 7 Total
Transmitted alleles 132 (77.6%) 38 (22.4%) 170
Non-transmitted 138 (81.2%) 32 (18.8%) 170
alleles
20% if we include 33 additional single parents, both
significantly different from the two control samples
(CHIP and TEDS) used in this study (x2 = 5.92, 1 df,
P = 0.015 and x2 = 7.00, 1 df, P = 0.008 respectively).
The results of the case-control analysis are consistent
with previous reports of a positive association between
the 7-repeat and ADHD. This was expected since we
had 95% power at an alpha level of 0.05 to confirm the
association, assuming an OR of 1.9. We attempted to
exclude the possibility of stratification by genotyping
control samples drawn from two independent sources
of English Caucasian children; one unselected for
phenotype (TEDS sample) and the other selected for
low maternal hyperactivity ratings (CHIP sample). Fur-
thermore, the frequency of the 7-repeat in published
reports of UK Caucasians shows a high level of consist-
ency with our data (Table 3). On the other hand,
within-family tests of association and linkage perfor-
med on the sub-set of 85 trios did not reach statistical
significance and showed only a very weak trend in the
expected direction. In this study, the power of the TDT
and HHRR tests are lower than the power of the case-
control analysis, since we analysed only 85 complete
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trios out of a total of 132 ADHD probands. To overcome
this problem we used TRANSMIT,2 which estimates
transmission ratios from the entire dataset by assigning
probabilities to parental genotypes where data are
missing from one or both parents and makes use of sib-
ling genotypes. This is a useful strategy in our sample
in which we have genotypes from 89 siblings.
Although TRANSMIT requires the estimation of allele
frequencies for the population and is no longer robust
to genetic stratification, we might expect a result close
to our case-control findings if non-replication was sim-
ply a matter of power. In fact, this was not what we
found since the transmission ratio estimate from
TRANSMIT showed an extremely weak and non-sig-
nificant trend in the expected direction (58 T vs 54
NT). The most obvious conclusion from these data is
therefore, that the case-control findings are false posi-
tive results, arising from a population stratification art-
efact.
The extent to which population stratification influ-
ences our findings may be estimated using procedures
described by Pritchard and colleagues,19 although the
data required for such an analysis do not exist at this
time. Nevertheless, in the light of reports from other
studies, it is worth considering alternative expla-
nations for these data. In a recent publication, Holmes
and colleagues, using UK Caucasian samples,11
reported a similar pattern of 7-repeat frequencies
among ADHD probands (n = 129), parents of probands
(n = 210) and unrelated controls (n = 425) to those seen
in this study. In both studies, the size of the gene effect
estimated from analysis of the case-control data was
larger compared to the estimate from within-family
data. Similar findings were reported in a recent meta-
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Table 3 Published 7-repeat allele frequencies among UK Caucasian controls
Study Region of Source of controls n alleles n 7-repeat Allele-7 freq.
ascertainment alleles
Lim et al17 London, England Non-psychiatric out-patients 118 16 13.6%
Daniels et al18 Cardiff, Wales Relatives of cases with non- 238 45 18.9%
psychiatric disorders
Holmes et al11 East Anglia & General practice register & 884 113 13.00%
Manchester, England non-psychiatric out-patients
CHIP-LOW SDQ England General practice register 178 26 14.61%
(this study)
TEDS CONTROL England Epidemiological twin sample 200 26 13.00%
(this study)
Combined total 1618 226 13.9%
analysis reported by Steve Faraone and colleagues.16
The analysis of 1266 cases and 3068 Caucasian con-
trols gave rise to an estimated odds ratio of 1.9 with a
significance level of 8 · 10 - 8, which meets Lander and
Kruglyak’s20 stringent criteria assuming a genome-wide
screen for association. In contrast an estimated odds
ratio of 1.4 came from the HHRR analysis of 1665 trios
with a lower level of significance (P = 0.02). If we
speculate that the observed difference in odds ratios is
a true difference, one of the consequences would be
considerably more power to replicate case-control fin-
dings than within-family tests. For HHRR analysis, we
have estimated that a sample size around 150 is needed
to detect the 7-repeat association assuming an odds
ratio of 1.9, whereas around 500 is required for an odds
ratio of 1.4, assuming 80% power and alpha level of
0.05. But is there any feasible explanation for such a
difference in odds ratios?
Holmes et al were the first to suggest this may indi-
cate gene–environment correlation.11 The 7-repeat
association may be primarily with the parents of ADHD
probands rather than with the ADHD probands them-
selves. In this scenario, the parental phenotype
resulting from possession of 7-repeat would give rise
to environmental risk factors for ADHD acting on off-
spring who do not carry copies of the 7-repeat, as well
as those that do: for example, hostile parenting and
poor parenting styles, or increased risk to the foetus
from higher rates of smoking, alcohol and other toxins
during pregnancy.
Is it possible that the increased rate of the 7-repeat
among parents of ADHD probands, compared to popu-
lation controls, is the result of assortative mating? We
have considered the effect of this on the TDT and
HHRR. For the TDT, estimates of odds ratio are robust
to changes in allele frequency and Hardy–Weinberg
Equilibrium (HWE) among parents, while for the HHRR
odds ratio is robust to changes in allele frequency but
decreases rapidly with departures from HWE (Sham,
unpublished observations). In our sample, both fathers
and mothers have an increased frequency of 7-repeats
compared to controls (18% and 23%, respectively), but
neither show any departure from HWE (data not
shown). We therefore conclude that assortative mating
is not expected to reduce the power of either analysis.
Finally, it has been frequently stated that the DRD4
exon 3 repeat polymorphism is functionally signifi-
cant. Asghari et al21 concluded that different repeat
lengths conferred different pharmacological properties
to the D4 receptor, with the 7-repeat acting to dull the
response of cells to dopamine. Such findings, however,
are not ubiquitous and more recent findings do not sug-
gest an important functional role for the repeat region.
Kazmi et al22 found no quantitative differences in G-
protein coupling when comparing constructs of the 2-,
4- and 7-repeat alleles. In another study of 2-, 4- and
7-repeats, Watts et al23 concluded that the potency and
efficacy of dopamine for sensitisation of cyclic-AMP
accumulation was comparable. Jovanovic et al24 com-
pared 2- and 10-repeats and found no major differences
in pharmacological or functional profiles for the two
receptors. It is therefore possible that the 7-repeat is in
linkage disequilibrium (LD) with a functional variant,
such as the DRD4 promotor polymorphism, reported
by Okuyama et al25 to reduce transcriptional efficiency
by around 40%. Variation in LD relationships found in
different populations may confound association stud-
ies with the 7-repeat allele, leading to discrepant find-
ings.
Methods
Clinical sample
Two clinical samples were used in this study collected
at the Institute of Psychiatry (IOP) and the University
of Birmingham (UB). Subjects were identified from
child behavioural clinics in London, Horsham, Sou-
thampton and Birmingham. Cases were referred for
assessment if they were thought by experienced clin-
icians to have a diagnosis of the combined subtype of
ADHD under DSM-IV criteria, with no significant Axis
I co-morbidity apart from oppositional defiant disorder
(ODD) and conduct disorder (CD). Parents of referred
cases were interviewed with an abbreviated version of
the Child and Adolescent Psychiatric Assessment
(CAPA).26 Information on ADHD symptoms at school
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were obtained using the Conners questionnaire.27 Fol-
lowing the IOP assessments, HYPESCHEME data
sheets were completed using data gathered from the
research interview, questionnaire and where necessary
review of case notes. HYPESCHEME is an operational
criteria checklist for ADHD and hyperkinetic disorders,
which summarises and applies DSM-IV and ICD-10
operational criteria.28 HYPESCHEME diagnoses were
checked against researcher applied DSM-IV criteria
and discrepancies reviewed by two researchers (PA
and SR). Where consensus could not be reached, cases
were brought to case conference and final consensus
agreement made with a senior clinical researcher (ET).
In the UB, DSM-IV criteria were applied directly by
the researcher (LK) and consensus diagnosis agreed at
case conference.
All the subjects used in this study were free of neuro-
logical disease and damage, and did not have any con-
genital disorders known to cause hyperactivity. They
were all Caucasian, aged between 5 and 15
(mean = 10.41, SD = 2.34) at the time of first assessment
and had an IQ above 60 (mean = 98.8, SD = 18.6, range
60–139). Cases were included in this study if they had
a diagnosis of ADHD under DSM-IV criteria. Out of 132
cases collected at the IOP, 120 had the combined sub-
type, nine had the hyperactive/impulsive subtype and
three the inattentive subtype. Out of 30 cases at UB, 24
had the combined subtype, four the hyperactive/
impulsive subtype and two the inattentive subtype.
Axis 1 comorbidity consisted of seven cases with an
affective disorder and two cases with Tourettes syn-
drome.
In addition, the IOP samples were screened for evi-
dence of pervasive developmental disorders (PDD)
using the Autism Screening Questionnaire (ASQ)29 and
the pro-social scale from the Strengths and Difficulties
Questionnaire (SDQ).30 In a pilot study, full Autism
Diagnostic Interviews were performed on eight ADHD
cases who scored high on these screening question-
naires and all of these were found to score above diag-
nostic cut-offs on the social communication domain
and five on at least one additional pervasive develop-
mental disorder (PDD) domain. Based on these data,
we identified 11 cases as having a questionnaire-based
diagnosis of PDD, defined as a score of 16 or greater on
the ASQ and five or less on the SDQ pro-social scale.
Control samples
Two independent epidemiologically obtained and eth-
nically matched control samples were used in this
study. Initial control data were generated from 100
children, aged 3–5 years who were part of the Twins
Early Development Study (TEDS). A second control
sample comprised children aged 5–15 years with low
hyperactivity scores on a parent rating scale. The five-
item hyperactivity scale from the SDQ was used with
selected controls scoring 0 or 1 on a 10-point scale. In
addition, we collected DNA from both parents when-
ever possible, for within-family tests of association and
linkage. Complete trio data were available from all 30
of the UB cases and 55 of the IOP cases. At the IOP,
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DNA was also collected from 89 siblings of ADHD pro-
bands.
Amplification of DRD4 exon 3 VNTR
The exon 3 VNTR was amplified with an initial 9-min
denaturing step at 95° C, followed by 35 cycles of 93° C
for 1 min, 55° C for 1 min and 72° C for 1 min, and a
final extension phase of 72° C for 10 min. Primers used
were 59-GGT CTG CGG TGG AGT CTG-39 and 59-GCG
ACT ACG TGG TCT ACT-39. Reactions were performed
in 22-ml volumes and included 50 ng of genomic DNA,
1.5 mM MgCl2, 0.2 mM dNTPs (incorporating a 50/50
deaza dGTP/dGTP mix), 10% DMSO, 10 mM Gene-
Amp 10· PCR Gold Buffer and 1 unit of AmpliTaq
Gold (PE Applied Biosystems, Foster City, CA, USA).
PCR products were run out on a 2% agarose gel stained
with ethidium bromide and analysed under UV light.
Homozygous genotypes were repeated if clear and
strong bands were not observed. The ability of this pro-
tocol to detect the long 7-repeat allele in heterozygotes,
which shows marked differential amplification with
the common 2, 3 and 4 repeat alleles, has been exam-
ined in our laboratory by comparison with fluor-
escently tagged products visualised on an ABI 310 (PE
Applied Biosystems) and found to be sufficiently
sensitive.
Statistical analysis
Association of the 7-repeat with ADHD was investi-
gated in the case-control data using the Pearson chi-
square statistic. The transmission disequilibrium test
(TDT) and haplotype-based haplotype relative risk
(HHRR) were applied to the sub-set of probands with
parental DNA available for genotyping. To maximise
the power of this sample for within-family tests, we
also applied TRANSMIT, a program which tests for
association between genetic marker and disease by
examining the transmission of markers from parents to
affected offspring. TRANSMIT can deal with unknown
parental genotypes and data from unaffected siblings
may be used to narrow down the range of possible par-
ental genotypes.
Acknowledgements
This research was funded by a Medical Research Coun-
cil (MRC) component grant to the Social Genetic Devel-
opmental Psychiatry Research Centre. Control samples
were collected with funds from a Wellcome Training
Fellowship to SC and UB samples were collected with
funds from a Wellcome Training Fellowship to LK. JM
is an MRC PhD student. We wish to thank all clinicians
and families who helped in this research. Particular
thanks go to Dr Geof Kewley, Dr Mark Berelowitz, Pro-
fessor Peter Hill, Fiona McNicholas, Mary Cameron
and Saama El Abd.
References
1 Collier DA, Curran S, Asherson P. Mission: not impossible? Candi-
date gene studies in child psychiatric disorders. Mol Psychiatry
2000; 5: 457–460.
ADHD and DRD4 in a UK sample
J Mill et al
444
Molecular Psychiatry
2 Clayton DG. A generalization of the transmission/disequilibrium
test for uncertain-haplotype transmission. Am J Hum Genet 1999;
65: 1170–1177.
3 Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver
A et al. Dopamine D4 gene 7-repeat allele and attention deficit hyp-
eractivity disorder. Am J Psychiatry 1999; 156: 768–770.
4 Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E,
Wigal T et al. Association of the dopamine receptor D4 (DRD4)
gene with a refined phenotype of attention deficit hyperactivity dis-
order (ADHD): a family-based approach. Mol Psychiatry 1998; 3:
38–41.
5 Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ,
Del’Homme MA et al. Evidence that the dopamine D4 receptor is
a susceptibility gene in attention deficit hyperactivity disorder. Mol
Psychiatry 1998; 3: 427–430.
6 Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH,
Terris ST et al. Dopamine DRD4 receptor polymorphism and atten-
tion deficit hyperactivity disorder. Mol Psychiatry 1998; 3: 419–
426.
7 LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et
al. Dopamine D4 receptor gene polymorphism is associated with
attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1:
121–124.
8 Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ.
Association and linkage of DRD4 and DRD5 with attention deficit
hyperactivity disorder (ADHD) in a sample of Turkish children.
Mol Psychiatry 2000; 5: 396–404.
9 Muglia P, Jain U, Macciardi F, Kennedy JL. Adult attention deficit
hyperactivity disorder and the dopamine D4 receptor gene. Am J
Med Genet 2000; 96: 273–277.
10 Sunohara GA, Roberts W, Malone M, Schachar R, Tannock R, Bas-
ile V et al. Linkage of the dopamine D4 receptor gene and attention-
deficit hyperactivity disorder (in press).
11 Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper
AL. et al. A family-based and case control association study of the
dopamine D4 receptor gene and dopamine transporter gene in
attention deficit hyperactivity disorder. Mol Psychiatry 2000; 5:
523–530.
12 Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN et al.
Lack of an association between a dopamine-4 receptor polymor-
phism and attention-deficit/hyperactivity disorder: genetic and
brain morphometric analyses. Mol Psychiatry 1998; 3: 431–434.
13 Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No
association of the dopamine DRD4 receptor (DRD4) gene polymor-
phism with attention deficit hyperactivity disorder (ADHD) in the
Irish population. Am J Med Genet 2000; 96: 268–272.
14 Eisenberg J, Zohar A, Mei-Tal G, Steinberg A, Tartakovsky E, Grit-
senko I et al. A haplotype relative risk study of the dopamine D4
receptor (DRD4) exon III repeat polymorphism and attention deficit
hyperactivity disorder (ADHD). Am J Med Genet 2000; 96: 258–261.
15 Kotler M, Manor I, Sever Y, Eisenberg J, Cohen H, Ebstein RP et
al. Failure to replicate an excess of the long dopamine D4 exon III
repeat polymorphism in ADHD in a family-based study. Am J Med
Genet 2000; 96: 278–281.
16 Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the
association between the dopamine D4 gene 7-repeat allele and
attention deficit hyperactivity disorder (in press).
17 Lim LCC, Nothen MM, Korner J, Rietschel M, Castle D, Hunt N et
al. No evidence of association between dopamine D4 receptor vari-
ants and bipolar affective disorder. Am J Med Genet 1994; 54:
259–263.
18 Daniels J, Williams J, Mant R, Asherson P, McGuffin P, Owen MJ.
Repeat length variation in the dopamine D4 receptor gene shows
no evidence of association with schizophrenia. Am J Med Genet
1994; 54: 256–258.
19 Pritchard JK, Stephens M, Rosenberg AN, Connelly P. Association
mapping in structured populations. Am J Hum Genet 2000; 67:
170–181.
20 Lander E, Kruglyak L. Genetic dissection of complex traits: guide-
lines for interpreting and reporting linkage results. Nature Genet
1995; 11: 241–247.
21 Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van
Tol HH. Modulation of intracellular cyclic AMP levels by different
human dopamine D4 receptor variants. J Neurochem 1995; 65:
1157–1165.
22 Kazmi MA, Snyder LA, Cypess AM, Graber SG, Sakmar TP. Selec-
tive reconstitution of human D4 dopamine receptor variants with
Gi alpha subtypes. Biochemistry 2000; 39: 3734–3744.
23 Watts VJ, Vu MN, Wiens BL, Jovanovic V, Van Tol HH, Neve KA.
S Psychopharmacology (Berl) 1999; 141: 83–92.
24 Jovanovic V, Guan HC, Van Tol HH. Comparative pharmacological
and functional analysis of the human dopamine D4.2 and D4.10
receptor variants. Pharmacogenetics 1999; 9: 561–568.
25 Okuyama Y, Ishiguro H, Nankai M, Shibuya H, Watanabe A, Arin-
ami T. Identification of a polymorphism in the promoter region of
DRD4 associated with the human novelty seeking personality trait.
Mol Psychiatry 2000; 5: 64–69.
26 Angold A, Costello E. A test-retest reliability study of child-
reported psychiatric symptoms and diagnoses using the Child and
Adolescent Psychiatric Assessment (CAPA-C). Psychol Med 1995;
25: 755–762.
27 Conners CK. The Conners rating scales: instruments for the assess-
ments of childhood psychopathology. Duke University, 1995.
28 Curran S, Newman S, Taylor E, Asherson P. Hypescheme: an oper-
ational criteria checklist and minimum data set for molecular gen-
etic studies of attention deficit and hyperactivity disorders. Am J
Med Genet 2000; 96: 244–250.
29 Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism
screening questionnaire: diagnostic validity. Br J Psychiatry 1999;
175: 444–451.
30 Goodman R. The strengths and difficulties questionnaire: a research
note. J Child Psychol Psychiatry & Appl Discip 1997; 38: 581–586.
Correspondence: Dr P Asherson, Social, Genetic, and Developmental
Psychiatry Research Centre, Institute of Psychiatry, De Crespigny
Park, London SE5 8AF, UK. E-mail: P.ashersonKiop.kcl.ac.uk
Received 16 October 2000; revised 16 January 2001; accepted 18 Janu-
ary 2001
